{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:53:03Z","timestamp":1792144383718,"version":"4.4.0"},"reference-count":63,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) is a progressive neurodegenerative disorder that accounts for the most cases of dementia. AD affects more than 25 million people globally and is predicted to affect nearly one in 85 people worldwide by 2050. AD is characterized by the accumulation of dense plaques of \u03b2-amyloid peptide (A\u03b2) and neurofibrillary tangles of hyperphosphorylated tau that cause impairment in memory, cognition, and daily activities. Although early-onset AD has been linked to several mutations, reliable genetic markers for late-onset AD are lacking. Further, the diagnosis of AD biomarkers has its limitations and cannot detect early-stage AD. The identification of accurate, early, and non-invasive biomarkers for AD is, therefore, an unmet challenge. Recently, microRNAs (miRNAs) have emerged as a novel class of gene regulatory elements with conserved roles in development and disease. Recent discoveries have uncovered roles of miRNAs in several model organisms during aging and have identified potential miRNAs biomarkers of AD. Here we will discuss this emerging field of miRNAs associated with AD and prospects for the future.<\/jats:p>","DOI":"10.1515\/bmc-2016-0014","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T03:52:41Z","timestamp":1470714761000},"page":"241-252","source":"Crossref","is-referenced-by-count":63,"title":["Alzheimer\u2019s disease: presence and role of microRNAs"],"prefix":"10.1515","volume":"7","author":[{"given":"Manasa","family":"Basavaraju","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, Quinnipiac University, Hamden, CT 06473, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"de Lencastre","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, Quinnipiac University, Hamden, CT 06473, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2016,8,9]]},"reference":[{"key":"2025120518140530544_j_bmc-2016-0014_ref_001_w2aab3b7b3b1b6b1ab2b3b1Aa","doi-asserted-by":"crossref","unstructured":"F\u00f6rstl H, Kurz A. Clinical features of Alzheimer\u2019s disease. Eur Arch Psychiatry Clin Neurosci 1999; 249: 288\u201390.","DOI":"10.1007\/s004060050101"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_002_w2aab3b7b3b1b6b1ab2b3b2Aa","doi-asserted-by":"crossref","unstructured":"Hardy J, Allsop D. Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease. Trends Pharmacol Sci 1991; 12: 383\u20138.","DOI":"10.1016\/0165-6147(91)90609-V"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_003_w2aab3b7b3b1b6b1ab2b3b3Aa","doi-asserted-by":"crossref","unstructured":"Waring SC, Rosenberg RN. Genome-wide association studies in Alzheimer disease. Arch Neurol 2008; 65: 329\u201334.","DOI":"10.1001\/archneur.65.3.329"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_004_w2aab3b7b3b1b6b1ab2b3b4Aa","doi-asserted-by":"crossref","unstructured":"Blennow K, de Leon MJ, Zetterberg H. Alzheimer\u2019s disease. Lancet Lond Engl 2006; 368: 387\u2013403.","DOI":"10.1016\/S0140-6736(06)69113-7"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_005_w2aab3b7b3b1b6b1ab2b3b5Aa","unstructured":"Pericak-Vance MA, Bebout JL, Gaskell PC, Yamaoka LH, Hung W-Y, Alberts MJ, Walker AP, Bartlett RJ, Haynes CA, Welsh KA. Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. Am J Hum Genet 1991; 48: 1034\u201350."},{"key":"2025120518140530544_j_bmc-2016-0014_ref_006_w2aab3b7b3b1b6b1ab2b3b6Aa","doi-asserted-by":"crossref","unstructured":"Van Cauwenberghe C, Van Broeckhoven C, Sleegers K. The genetic landscape of Alzheimer disease: clinical implications and perspectives. Genet Med Off J Am Coll Med Genet 2016; 18: 421\u201330.","DOI":"10.1038\/gim.2015.117"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_007_w2aab3b7b3b1b6b1ab2b3b7Aa","doi-asserted-by":"crossref","unstructured":"Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 1993; 261: 921\u20133.","DOI":"10.1126\/science.8346443"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_008_w2aab3b7b3b1b6b1ab2b3b8Aa","doi-asserted-by":"crossref","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 1977\u201381.","DOI":"10.1073\/pnas.90.5.1977"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_009_w2aab3b7b3b1b6b1ab2b3b9Aa","doi-asserted-by":"crossref","unstructured":"Hauser PS, Ryan RO. Impact of apolipoprotein E on Alzheimer\u2019s disease. Curr Alzheimer Res 2013; 10: 809\u201317.","DOI":"10.2174\/15672050113109990156"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_010_w2aab3b7b3b1b6b1ab2b3c10Aa","doi-asserted-by":"crossref","unstructured":"Deane R, Sagare A, Hamm K, Parisi M, Lane S, Finn MB, Holtzman DM, Zlokovic BV. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. J Clin Invest 2008; 118: 4002\u201313.","DOI":"10.1172\/JCI36663"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_011_w2aab3b7b3b1b6b1ab2b3c11Aa","doi-asserted-by":"crossref","unstructured":"Nistor M, Don M, Parekh M, Sarsoza F, Goodus M, Lopez GE, Kawas C, Leverenz J, Doran E, Lott IT, Hill M, Head E. Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain. Neurobiol Aging 2007; 28: 1493\u2013506.","DOI":"10.1016\/j.neurobiolaging.2006.06.023"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_012_w2aab3b7b3b1b6b1ab2b3c12Aa","doi-asserted-by":"crossref","unstructured":"McConathy J, Sheline YI. Imaging biomarkers associated with cognitive decline: a review. Biol Psychiatry 2015; 77: 685\u201392.","DOI":"10.1016\/j.biopsych.2014.08.024"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_013_w2aab3b7b3b1b6b1ab2b3c13Aa","doi-asserted-by":"crossref","unstructured":"Sabri O, Sabbagh MN, Seibyl J, Barthel H, Akatsu H, Ouchi Y, Senda K, Murayama S, Ishii K, Takao M, Beach TG, Rowe CC, Leverenz JB, Ghetti B, Ironside JW, Catafau AM, Stephens AW, Mueller A, Koglin N, Hoffmann A, Roth K, Reininger C, Schulz-Schaeffer WJ. Florbetaben Phase 3 Study Group. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer\u2019s disease: Phase 3 study. Alzheimers Dement 2015; 11: 964\u201374.","DOI":"10.1016\/j.jalz.2015.02.004"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_014_w2aab3b7b3b1b6b1ab2b3c14Aa","doi-asserted-by":"crossref","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281\u201397.","DOI":"10.1016\/S0092-8674(04)00045-5"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_015_w2aab3b7b3b1b6b1ab2b3c15Aa","doi-asserted-by":"crossref","unstructured":"Macfarlane L-A, Murphy PR. MicroRNA: biogenesis, function and role in cancer. Curr Genomics 2010; 11: 537\u201361.","DOI":"10.2174\/138920210793175895"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_016_w2aab3b7b3b1b6b1ab2b3c16Aa","doi-asserted-by":"crossref","unstructured":"Friedman DB, Johnson TE. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics 1988; 118: 75\u201386.","DOI":"10.1093\/genetics\/118.1.75"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_017_w2aab3b7b3b1b6b1ab2b3c17Aa","doi-asserted-by":"crossref","unstructured":"Kenyon CJ. The genetics of ageing. Nature 2010; 464: 504\u201312.","DOI":"10.1038\/nature08980"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_018_w2aab3b7b3b1b6b1ab2b3c18Aa","doi-asserted-by":"crossref","unstructured":"Boehm M, Slack F. A developmental timing microRNA and its target regulate life span in C. elegans. Science 2005; 310: 1954\u20137.","DOI":"10.1126\/science.1115596"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_019_w2aab3b7b3b1b6b1ab2b3c19Aa","doi-asserted-by":"crossref","unstructured":"Mari\u00f1o G, Ugalde AP, Fern\u00e1ndez AF, Osorio FG, Fueyo A, Freije JM, L\u00f3pez-Ot\u00edn C. Insulin-like growth factor 1 treatment extends longevity in a mouse model of human premature aging by restoring somatotroph axis function. Proc Natl Acad Sci USA 2010; 107: 16268\u201373.","DOI":"10.1073\/pnas.1002696107"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_020_w2aab3b7b3b1b6b1ab2b3c20Aa","doi-asserted-by":"crossref","unstructured":"Inukai S, de Lencastre A, Turner M, Slack F. Novel m icroRNAs differentially expressed during aging in the mouse brain. Watson M, editor. PLoS One 2012; 7: e40028.","DOI":"10.1371\/journal.pone.0040028"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_021_w2aab3b7b3b1b6b1ab2b3c21Aa","doi-asserted-by":"crossref","unstructured":"Nissan X, Blondel S, Navarro C, Maury Y, Denis C, Girard M, Martinat C, De Sandre-Giovannoli A, Levy N, Peschanski M. Unique preservation of neural cells in Hutchinson-Gilford progeria syndrome is due to the expression of the neural-specific miR-9 microRNA. Cell Rep 2012; 2: 1\u20139.","DOI":"10.1016\/j.celrep.2012.05.015"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_022_w2aab3b7b3b1b6b1ab2b3c22Aa","doi-asserted-by":"crossref","unstructured":"Van den Hove DL, Kompotis K, Lardenoije R, Kenis G, Mill J, Steinbusch HW, Lesch KP, Fitzsimons CP, De Strooper B, Rutten BP. Epigenetically regulated microRNAs in Alzheimer\u2019s disease. Neurobiol Aging 2014; 35: 731\u201345.","DOI":"10.1016\/j.neurobiolaging.2013.10.082"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_023_w2aab3b7b3b1b6b1ab2b3c23Aa","doi-asserted-by":"crossref","unstructured":"Sethi P, Lukiw WJ. Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer\u2019s disease temporal lobe neocortex. Neurosci Lett 2009; 459: 100\u20134.","DOI":"10.1016\/j.neulet.2009.04.052"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_024_w2aab3b7b3b1b6b1ab2b3c24Aa","doi-asserted-by":"crossref","unstructured":"Femminella GD, Ferrara N, Rengo G. The emerging role of microRNAs in Alzheimer\u2019s disease. Front Physiol 2015; 6: 40.","DOI":"10.3389\/fphys.2015.00040"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_025_w2aab3b7b3b1b6b1ab2b3c25Aa","doi-asserted-by":"crossref","unstructured":"Qiu L, Tan EK, Zeng L. microRNAs and neurodegenerative diseases. Adv Exp Med Biol 2015; 888: 85\u2013105.","DOI":"10.1007\/978-3-319-22671-2_6"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_026_w2aab3b7b3b1b6b1ab2b3c26Aa","doi-asserted-by":"crossref","unstructured":"Cohen E, Bieschke J, Perciavalle RM, Kelly JW, Dillin A. Opposing activities protect against age-onset proteotoxicity. Science 2006; 313: 1604\u201310.","DOI":"10.1126\/science.1124646"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_027_w2aab3b7b3b1b6b1ab2b3c27Aa","doi-asserted-by":"crossref","unstructured":"Noren Hooten N, Abdelmohsen K, Gorospe M, Ejiogu N, Zonderman AB, Evans MK. microRNA expression patterns reveal differential expression of target genes with age. Blagosklonny MV, editor. PLoS One 2010; 5: e10724.","DOI":"10.1371\/journal.pone.0010724"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_028_w2aab3b7b3b1b6b1ab2b3c28Aa","doi-asserted-by":"crossref","unstructured":"Mogilyansky E, Rigoutsos I. The miR-17\/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease. Cell Death Differ 2013; 20: 1603\u201314.","DOI":"10.1038\/cdd.2013.125"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_029_w2aab3b7b3b1b6b1ab2b3c29Aa","doi-asserted-by":"crossref","unstructured":"Dickson JR, Kruse C, Montagna DR, Finsen B, Wolfe MS. Alternative polyadenylation and miR-34 family members regulate tau expression. J Neurochem 2013; 127: 739\u201349.","DOI":"10.1111\/jnc.12437"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_030_w2aab3b7b3b1b6b1ab2b3c30Aa","doi-asserted-by":"crossref","unstructured":"de Lencastre A, Pincus Z, Zhou K, Kato M, Lee SS, Slack FJ. MicroRNAs both promote and antagonize longevity in C. elegans. Curr Biol 2010; 20: 2159\u201368.","DOI":"10.1016\/j.cub.2010.11.015"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_031_w2aab3b7b3b1b6b1ab2b3c31Aa","doi-asserted-by":"crossref","unstructured":"Varghese J, Cohen SM. microRNA miR-14 acts to modulate a positive autoregulatory loop controlling steroid hormone signaling in Drosophila. Genes Dev 2007; 21: 2277\u201382.","DOI":"10.1101\/gad.439807"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_032_w2aab3b7b3b1b6b1ab2b3c32Aa","doi-asserted-by":"crossref","unstructured":"Garg D, Cohen SM. miRNAs and aging: a genetic perspective. Ageing Res Rev 2014; 17: 3\u20138.","DOI":"10.1016\/j.arr.2014.04.001"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_033_w2aab3b7b3b1b6b1ab2b3c33Aa","doi-asserted-by":"crossref","unstructured":"Yang J, Chen D, He Y, Mel\u00e9ndez A, Feng Z, Hong Q, Bai X, Li Q, Cai G, Wang J, Chen X. MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9. Age 2013; 35: 11\u201322.","DOI":"10.1007\/s11357-011-9324-3"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_034_w2aab3b7b3b1b6b1ab2b3c34Aa","doi-asserted-by":"crossref","unstructured":"Hyun S, Lee JH, Jin H, Nam J, Namkoong B, Lee G, Chung J, Kim VN. Conserved microRNA miR-8\/miR-200 and its target USH\/FOG2 control growth by regulating PI3K. Cell 2009; 139: 1096\u2013108.","DOI":"10.1016\/j.cell.2009.11.020"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_035_w2aab3b7b3b1b6b1ab2b3c35Aa","doi-asserted-by":"crossref","unstructured":"Karres JS, Hilgers V, Carrera I, Treisman J, Cohen SM. The Conserved microRNA MiR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila. Cell 2007; 131: 136\u201345.","DOI":"10.1016\/j.cell.2007.09.020"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_036_w2aab3b7b3b1b6b1ab2b3c36Aa","doi-asserted-by":"crossref","unstructured":"Grillari J, Hackl M, Grillari-Voglauer R. miR-17-92 cluster: ups and downs in cancer and aging. Biogerontology 2010; 11: 501\u20136.","DOI":"10.1007\/s10522-010-9272-9"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_037_w2aab3b7b3b1b6b1ab2b3c37Aa","doi-asserted-by":"crossref","unstructured":"Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, Li QJ, Lowe SW, Hannon GJ, He L. miR-19 is a key oncogenic component of mir-17-92. Genes Dev 2009; 23: 2839\u201349.","DOI":"10.1101\/gad.1861409"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_038_w2aab3b7b3b1b6b1ab2b3c38Aa","doi-asserted-by":"crossref","unstructured":"Liu N, Landreh M, Cao K, Abe M, Hendriks G-J, Kennerdell JR, Zhu Y, Wang LS, Bonini NM. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 2012; 482: 519\u201323.","DOI":"10.1038\/nature10810"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_039_w2aab3b7b3b1b6b1ab2b3c39Aa","doi-asserted-by":"crossref","unstructured":"Ib\u00e1\u00f1ez-Ventoso C, Yang M, Guo S, Robins H, Padgett RW, Driscoll M. Modulated microRNA expression during adult lifespan in Caenorhabditis elegans. Aging Cell 2006; 5: 235\u201346.","DOI":"10.1111\/j.1474-9726.2006.00210.x"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_040_w2aab3b7b3b1b6b1ab2b3c40Aa","doi-asserted-by":"crossref","unstructured":"Zovoilis A, Agbemenyah HY, Agis-Balboa RC, Stilling RM, Edbauer D, Rao P, Farinelli L, Delalle I, Schmitt A, Falkai P, Bahari-Javan S, Burkhardt S, Sananbenesi F, Fischer A. microRNA-34c is a novel target to treat dementias. EMBO J 2011; 30: 4299\u2013308.","DOI":"10.1038\/emboj.2011.327"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_041_w2aab3b7b3b1b6b1ab2b3c41Aa","doi-asserted-by":"crossref","unstructured":"Gaughwin PM, Ciesla M, Lahiri N, Tabrizi SJ, Brundin P, Bj\u00f6rkqvist M. Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington\u2019s disease. Hum Mol Genet 2011; 20: 2225\u201337.","DOI":"10.1093\/hmg\/ddr111"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_042_w2aab3b7b3b1b6b1ab2b3c42Aa","doi-asserted-by":"crossref","unstructured":"Garza-Manero S, Arias C, Berm\u00fadez-Rattoni F, Vaca L, Zepeda A. Identification of age- and disease-related alterations in circulating miRNAs in a mouse model of Alzheimer\u2019s disease. Front Cell Neurosci 2015; 9: 53.","DOI":"10.3389\/fncel.2015.00053"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_043_w2aab3b7b3b1b6b1ab2b3c43Aa","doi-asserted-by":"crossref","unstructured":"M\u00fcller M, J\u00e4kel L, Bruinsma IB, Claassen JA, Kuiperij HB, Verbeek MM. MicroRNA-29a is a candidate biomarker for Alzheimer\u2019s disease in cell-free cerebrospinal fluid. Mol Neurobiol 2016; 53: 2894\u20139.","DOI":"10.1007\/s12035-015-9156-8"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_044_w2aab3b7b3b1b6b1ab2b3c44Aa","doi-asserted-by":"crossref","unstructured":"Grasso M, Piscopo P, Crestini A, Confaloni A, Denti MA. Circulating microRNAs in neurodegenerative diseases. EXS 2015; 106: 151\u201369.","DOI":"10.1007\/978-3-0348-0955-9_7"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_045_w2aab3b7b3b1b6b1ab2b3c45Aa","doi-asserted-by":"crossref","unstructured":"Schipper HM, Maes OC, Chertkow HM, Wang E. MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul Syst Biol 2007; 1: 263\u201374.","DOI":"10.4137\/GRSB.S361"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_046_w2aab3b7b3b1b6b1ab2b3c46Aa","doi-asserted-by":"crossref","unstructured":"Lukiw WJ. Micro-RNA speciation in fetal, adult and Alzheimer\u2019s disease hippocampus. Neuroreport 2007; 18: 297\u2013300.","DOI":"10.1097\/WNR.0b013e3280148e8b"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_047_w2aab3b7b3b1b6b1ab2b3c47Aa","doi-asserted-by":"crossref","unstructured":"Cogswell JP, Ward J, Taylor IA, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J, Brown D, Chen C, Prinjha RK, Richardson JC, Saunders AM, Roses AD, Richards CA. Identification of miRNA changes in Alzheimer\u2019s disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis 2008; 14: 27\u201341.","DOI":"10.3233\/JAD-2008-14103"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_048_w2aab3b7b3b1b6b1ab2b3c48Aa","doi-asserted-by":"crossref","unstructured":"H\u00e9bert SS, Horr\u00e9 K, Nicola\u00ef L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, Kauppinen S, Delacourte A, De Strooper B. Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/beta-secretase expression. Proc Natl Acad Sci USA 2008; 105: 6415\u201320.","DOI":"10.1073\/pnas.0710263105"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_049_w2aab3b7b3b1b6b1ab2b3c49Aa","doi-asserted-by":"crossref","unstructured":"Sala Frigerio C, Lau P, Salta E, Tournoy J, Bossers K, Vandenberghe R, Wallin A, Bjerke M, Zetterberg H, Blennow K, De Strooper B. Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease. Neurology 2013; 81: 2103\u20136.","DOI":"10.1212\/01.wnl.0000437306.37850.22"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_050_w2aab3b7b3b1b6b1ab2b3c50Aa","doi-asserted-by":"crossref","unstructured":"Lukiw WJ. NF-\u03baB-regulated micro RNAs (miRNAs) in primary human brain cells. Exp Neurol 2012; 235: 484\u201390.","DOI":"10.1016\/j.expneurol.2011.11.022"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_051_w2aab3b7b3b1b6b1ab2b3c51Aa","doi-asserted-by":"crossref","unstructured":"Wang X, Liu P, Zhu H, Xu Y, Ma C, Dai X, Huang L, Liu Y, Zhang L, Qin C. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer\u2019s disease, inhibits bcl2 translation. Brain Res Bull 2009; 80: 268\u201373.","DOI":"10.1016\/j.brainresbull.2009.08.006"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_052_w2aab3b7b3b1b6b1ab2b3c52Aa","doi-asserted-by":"crossref","unstructured":"Lukiw WJ, Andreeva TV, Grigorenko AP, Rogaev EI. Studying micro RNA function and dysfunction in Alzheimer\u2019s disease. Front Genet 2012; 3: 327.","DOI":"10.3389\/fgene.2012.00327"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_053_w2aab3b7b3b1b6b1ab2b3c53Aa","doi-asserted-by":"crossref","unstructured":"Navarro F, Lieberman J. miR-34 and p53: new insights into a complex functional relationship. PLoS One 2015; 10: e0132767.","DOI":"10.1371\/journal.pone.0132767"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_054_w2aab3b7b3b1b6b1ab2b3c54Aa","doi-asserted-by":"crossref","unstructured":"H\u00e9bert SS, Horr\u00e9 K, Nicola\u00ef L, Bergmans B, Papadopoulou AS, Delacourte A, De Strooper B. MicroRNA regulation of Alzheimer\u2019s Amyloid precursor protein expression. Neurobiol Dis 2009; 33: 422\u20138.","DOI":"10.1016\/j.nbd.2008.11.009"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_055_w2aab3b7b3b1b6b1ab2b3c55Aa","doi-asserted-by":"crossref","unstructured":"Kim J, Yoon H, Ram\u00edrez CM, Lee S-M, Hoe H-S, Fern\u00e1ndez-Hernando C, Kim J. miR-106b impairs cholesterol efflux and increases A\u03b2 levels by repressing ABCA1 expression. Exp Neurol 2012; 235: 476\u201383.","DOI":"10.1016\/j.expneurol.2011.11.010"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_056_w2aab3b7b3b1b6b1ab2b3c56Aa","doi-asserted-by":"crossref","unstructured":"Lukiw WJ, Alexandrov PN, Zhao Y, Hill JM, Bhattacharjee S. Spreading of Alzheimer\u2019s disease inflammatory signaling through soluble micro-RNA. Neuroreport 2012; 23: 621\u20136.","DOI":"10.1097\/WNR.0b013e32835542b0"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_057_w2aab3b7b3b1b6b1ab2b3c57Aa","doi-asserted-by":"crossref","unstructured":"Song J, Lee JE. miR-155 is involved in Alzheimer\u2019s disease by regulating T lymphocyte function. Front Aging Neurosci 2015; 7: 61.","DOI":"10.3389\/fnagi.2015.00061"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_058_w2aab3b7b3b1b6b1ab2b3c58Aa","doi-asserted-by":"crossref","unstructured":"Wang J, Chen J, Sen S. MicroRNA as biomarkers and diagnostics. J Cell Physiol 2016; 231: 25\u201330.","DOI":"10.1002\/jcp.25056"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_059_w2aab3b7b3b1b6b1ab2b3c59Aa","unstructured":"Alexandrov PN, Dua P, Hill JM, Bhattacharjee S, Zhao Y, Lukiw WJ. MicroRNA (miRNA) speciation in Alzheimer\u2019s disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). Int J Biochem Mol Biol 2012; 3: 365\u201373."},{"key":"2025120518140530544_j_bmc-2016-0014_ref_060_w2aab3b7b3b1b6b1ab2b3c60Aa","doi-asserted-by":"crossref","unstructured":"Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011; 11: 849\u201364.","DOI":"10.1038\/nrc3166"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_061_w2aab3b7b3b1b6b1ab2b3c61Aa","doi-asserted-by":"crossref","unstructured":"Miller VM, Gouvion CM, Davidson BL, Paulson HL. Targeting Alzheimer\u2019s disease genes with RNA interference: an efficient strategy for silencing mutant alleles. Nucleic Acids Res 2004; 32: 661\u20138.","DOI":"10.1093\/nar\/gkh208"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_062_w2aab3b7b3b1b6b1ab2b3c62Aa","doi-asserted-by":"crossref","unstructured":"Xie Z, Dong Y, Maeda U, Xia W, Tanzi RE. RNA interference silencing of the adaptor molecules ShcC and Fe65 differentially affect amyloid precursor protein processing and A\u03b2 generation. J Biol Chem 2007; 282: 4318\u201325.","DOI":"10.1074\/jbc.M609293200"},{"key":"2025120518140530544_j_bmc-2016-0014_ref_063_w2aab3b7b3b1b6b1ab2b3c63Aa","doi-asserted-by":"crossref","unstructured":"Singer O, Marr RA, Rockenstein E, Crews L, Coufal NG, Gage FH, Verma IM, Masliah E. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci 2005; 8: 1343\u20139.","DOI":"10.1038\/nn1531"}],"container-title":["Biomolecular Concepts"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/bmc\/7\/4\/article-p241.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/bmc-2016-0014\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/bmc-2016-0014\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T18:44:05Z","timestamp":1764960245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/bmc-2016-0014\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,1]]},"references-count":63,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,8,9]]},"published-print":{"date-parts":[[2016,8,1]]}},"alternative-id":["10.1515\/bmc-2016-0014"],"URL":"https:\/\/doi.org\/10.1515\/bmc-2016-0014","relation":{},"ISSN":["1868-503X","1868-5021"],"issn-type":[{"value":"1868-503X","type":"electronic"},{"value":"1868-5021","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8,1]]}}}